Citation: | Yang L,Yang QW,Fu YJ.Research advances on the pathogenesis and diagnosis of pyoderma gangrenosum[J].Chin J Burns Wounds,2022,38(6):569-573.DOI: 10.3760/cma.j.cn501225-20220331-00117. |
[1] |
Smith-PliegoM,Contreras-RuizJ,RyanS,et al.Cutaneous malakoplakia masquerading as pyoderma gangrenosum[J].Int Wound J,2017,14(4):658-660.DOI: 10.1111/iwj.12661.
|
[2] |
LanganSM,GrovesRW,CardTR,et al.Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study[J].J Invest Dermatol,2012,132(9):2166-2170.DOI: 10.1038/jid.2012.130.
|
[3] |
AlaviA,FrenchLE,DavisMD,et al.Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment[J].Am J Clin Dermatol,2017,18(3):355-372.DOI: 10.1007/s40257-017-0251-7.
|
[4] |
Greenlee-WackerMC.Clearance of apoptotic neutrophils and resolution of inflammation[J].Immunol Rev,2016,273(1):357-370.DOI: 10.1111/imr.12453.
|
[5] |
SatohTK,MellettM,ContassotE,et al.Are neutrophilic dermatoses autoinflammatory disorders?[J].Br J Dermatol,2018,178(3):603-613.DOI: 10.1111/bjd.15105.
|
[6] |
Vignon-PennamenMD,WallachD.Cutaneous manifestations of neutrophilic disease. A study of seven cases[J].Dermatologica,1991,183(4):255-264.DOI: 10.1159/000247696.
|
[7] |
MistryP,Carmona-RiveraC,OmbrelloAK,et al.Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome[J].Ann Rheum Dis,2018,77(12):1825-1833.DOI: 10.1136/annrheumdis-2018-213746.
|
[8] |
WangY,LiM,StadlerS,et al.Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation[J].J Cell Biol,2009,184(2):205-213.DOI: 10.1083/jcb.200806072.
|
[9] |
SørensenOE,BorregaardN.Neutrophil extracellular traps - the dark side of neutrophils[J].J Clin Invest,2016,126(5):1612-1620.DOI: 10.1172/JCI84538.
|
[10] |
PapayannopoulosV.Neutrophil extracellular traps in immunity and disease[J].Nat Rev Immunol,2018,18(2):134-147.DOI: 10.1038/nri.2017.105.
|
[11] |
AdachiY,KindzelskiiAL,CookinghamG,et al.Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum[J].J Invest Dermatol,1998,111(2):259-268.DOI: 10.1046/j.1523-1747.1998.00311.x.
|
[12] |
McKenzieF,ArthurM,Ortega-LoayzaAG. Pyoderma gangrenosum: what do we know now?[J]. Current Dermatology Reports,2018,7(4):147-157.DOI: 10.1007/s13671-018-0224-y.
|
[13] |
AntonelliE,BassottiG,TramontanaM,et al.Dermatological manifestations in inflammatory bowel diseases[J].J Clin Med,2021,10(2):364.DOI: 10.3390/jcm10020364.
|
[14] |
CugnoM,BorghiA,MarzanoAV.PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment[J].Am J Clin Dermatol,2017,18(4):555-562.DOI: 10.1007/s40257-017-0265-1.
|
[15] |
PlumptreI,KnabelD,TomeckiK.Pyoderma gangrenosum: a review for the gastroenterologist[J].Inflamm Bowel Dis,2018,24(12):2510-2517.DOI: 10.1093/ibd/izy174.
|
[16] |
HobbsMM,Ortega-LoayzaAG.Pyoderma gangrenosum: from historical perspectives to emerging investigations[J].Int Wound J,2020,17(5):1255-1265.DOI: 10.1111/iwj.13389.
|
[17] |
MaverakisE,MarzanoAV,LeST,et al.Pyoderma gangrenosum[J].Nat Rev Dis Primers,2020,6(1):81.DOI: 10.1038/s41572-020-0213-x.
|
[18] |
WangEA,SteelA,LuxardiG,et al.Classic ulcerative pyoderma gangrenosum is a T cell-mediated disease targeting follicular adnexal structures: a hypothesis based on molecular and clinicopathologic studies[J].Front Immunol,2018,8:1980.DOI: 10.3389/fimmu.2017.01980.
|
[19] |
CaproniM,AntigaE,VolpiW,et al.The Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum[J].Br J Dermatol,2015,173(1):275-278.DOI: 10.1111/bjd.13670.
|
[20] |
QuaglinoP,FavaP,CaproniM,et al.Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group[J].J Eur Acad Dermatol Venereol,2016,30(4):655-658.DOI: 10.1111/jdv.13100.
|
[21] |
NesterovitchAB,GyorfyZ,HoffmanMD,et al.Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses[J].Am J Pathol,2011,178(4):1434-1441.DOI: 10.1016/j.ajpath.2010.12.035.
|
[22] |
NesterovitchAB,SzantoS,GondaA,et al.Spontaneous insertion of a b2 element in the Ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans[J].Am J Pathol,2011,178(4):1701-1714.DOI: 10.1016/j.ajpath.2010.12.053.
|
[23] |
NesterovitchAB,ArbievaZ,TothDM,et al.A differential gene expression study: Ptpn6 (SHP-1)-insufficiency leads to neutrophilic dermatosis-like disease (NDLD) in mice[J].J Dermatol Sci,2016,83(1):17-25.DOI: 10.1016/j.jdermsci.2016.03.005.
|
[24] |
SoodAK,McShaneDB,GoogePB,et al.Successful treatment of PAPA syndrome with dual adalimumab and tacrolimus therapy[J].J Clin Immunol,2019,39(8):832-835.DOI: 10.1007/s10875-019-00685-6.
|
[25] |
WangY,WuN,YuK,et al.Case report: pyogenic arthritis, pyoderma gangrenosum, and acne: a single-center experience and literature review[J].Front Immunol,2021,12:735851.DOI: 10.3389/fimmu.2021.735851.
|
[26] |
MaitrepierreF,MarzanoAV,LipskerD.A unified concept of acne in the PAPA spectrum disorders[J].Dermatology,2021,237(5):827-834.DOI: 10.1159/000509874.
|
[27] |
AhnC,NegusD,HuangW.Pyoderma gangrenosum: a review of pathogenesis and treatment[J].Expert Rev Clin Immunol,2018,14(3):225-233.DOI: 10.1080/1744666X.2018.1438269.
|
[28] |
Alonso-LeónT,Hernández-RamírezHH,Fonte-AvalosV,et al.The great imitator with no diagnostic test: pyoderma gangrenosum[J].Int Wound J,2020,17(6):1774-1782.DOI: 10.1111/iwj.13466.
|
[29] |
GeorgeC,DeroideF,RustinM.Pyoderma gangrenosum - a guide to diagnosis and management[J].Clin Med (Lond),2019,19(3):224-228.DOI: 10.7861/clinmedicine.19-3-224.
|
[30] |
SullivanSN.Bullous pyoderma gangrenosum and inflammatory bowel disease[J].Inflamm Bowel Dis,2018,24(5):e16-e17.DOI: 10.1093/ibd/izy018.
|
[31] |
ShavitE,CecchiniM,LimacherJJ,et al.Superficial granulomatous pyoderma gangrenosum involving the face: a case series of five patients and a review of the literature [formula: see text][J].J Cutan Med Surg,2021,25(4):371-376.DOI: 10.1177/1203475420988864.
|
[32] |
AfifiL,SanchezIM,WallaceMM,et al.Diagnosis and management of peristomal pyoderma gangrenosum: a systematic review[J].J Am Acad Dermatol,2018,78(6):1195-1204.e1.DOI: 10.1016/j.jaad.2017.12.049.
|
[33] |
PearsonWA,PrenticeDA,SinclairDL,et al.A novel topical therapy for resistant and early peristomal pyoderma gangrenosum[J].Int Wound J,2019,16(5):1136-1143.DOI: 10.1111/iwj.13164.
|
[34] |
XuA,BalgobindA,StrunkA,et al.Prevalence estimates for pyoderma gangrenosum in the United States: an age- and sex-adjusted population analysis[J].J Am Acad Dermatol,2020,83(2):425-429.DOI: 10.1016/j.jaad.2019.08.001.
|
[35] |
GuptaAS,Ortega-LoayzaAG.Ocular pyoderma gangrenosum: a systematic review[J].J Am Acad Dermatol,2017,76(3):512-518.DOI: 10.1016/j.jaad.2016.08.049.
|
[36] |
ScherlingerM,GuilletS,DoutreMS,et al.Pyoderma gangrenosum with extensive pulmonary involvement[J].J Eur Acad Dermatol Venereol,2017,31(4):e214-e216.DOI: 10.1111/jdv.13976.
|
[37] |
KridinK,CohenAD,AmberKT.Underlying systemic diseases in pyoderma gangrenosum: a systematic review and meta-analysis[J].Am J Clin Dermatol,2018,19(4):479-487.DOI: 10.1007/s40257-018-0356-7.
|
[38] |
WallachD,Vignon-PennamenMD.Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses[J].Br J Dermatol,2018,178(3):595-602.DOI: 10.1111/bjd.13955.
|
[39] |
FloraA,KozeraE,FrewJW.Pyoderma gangrenosum: a systematic review of the molecular characteristics of disease[J].Exp Dermatol,2022,31(4):498-515.DOI: 10.1111/exd.14534.
|
[40] |
MarzanoAV,BorghiA,WallachD,et al.A comprehensive review of neutrophilic diseases[J].Clin Rev Allergy Immunol,2018,54(1):114-130.DOI: 10.1007/s12016-017-8621-8.
|
[41] |
LandisET,TaheriA,JorizzoJL.Gulliver's sign: a recognizable transition from inflammatory to healing stages of pyoderma gangrenosum[J].J Dermatolog Treat,2015,26(2):171-172.DOI: 10.3109/09546634.2014.883061.
|
[42] |
SkopisM,ElghawyAA,PociurkoB,et al.Pyoderma gangrenosum associated with limited cutaneous systemic sclerosis: a rare case with literature review[J].Clin Rheumatol,2021,40(3):1141-1145.DOI: 10.1007/s10067-020-05285-z.
|
[43] |
JockenhöferF,WollinaU,SalvaKA,et al.The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum[J].Br J Dermatol,2019,180(3):615-620.DOI: 10.1111/bjd.16401.
|
[44] |
MaverakisE,MaC,ShinkaiK,et al.Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts[J].JAMA Dermatol,2018,154(4):461-466.DOI: 10.1001/jamadermatol.2017.5980.
|
[45] |
GoldustM,HagstromEL,RathodD,et al.Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum[J].Expert Rev Clin Pharmacol,2020,13(2):157-161.DOI: 10.1080/17512433.2020.1709825.
|
[1] | Expert consensus on diagnosis and treatment of radiation-induced skin injury (2024 version)[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2024, 40(8): 701-712. doi: 10.3760/cma.j.cn501225-20240126-00033 |
[2] | Practical guidelines for the diagnosis, prevention and treatment of invasive fungal infection post burn injury in China: 2024 edition[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2024, 40(7): 604-617. doi: 10.3760/cma.j.cn501225-20240103-00003 |
[3] | He Ting, Liu Wei, Shen Chuan'an. Research advances on application of pancreatic stone protein in the early diagnosis of sepsis[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2023, 39(10): 985-988. doi: 10.3760/cma.j.cn501225-20221120-00498 |
[4] | Li Yang, Wang Yuanyuan, Xing Ke, Li Shanshan. Current situation and the latest progress in the treatment of pyoderma gangrenosum[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2022, 38(6): 574-579. doi: 10.3760/cma.j.cn501225-20220330-00108 |
[5] | Zhao Jingfeng, Hao Daifeng, Li Tao, Feng Guang. Analysis of clinical features and treatment of pyoderma gangrenosum[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2022, 38(6): 506-511. doi: 10.3760/cma.j.cn501225-20220317-00068 |
[6] | Liu Jiang, Liu Yi. Research advances on the formation mechanism and diagnosis of bacteria biofilms in chronic wounds[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2021, 37(7): 692-696. doi: 10.3760/cma.j.cn501120-20200327-00198 |
[7] | Zhou Jinxiu, Jiang Zhengying, Liu Mingzhuo, Guo Guanghua. Advances in the research of diagnosis and treatment of ventilator-induced lung injury after burn[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(2): 137-141. doi: 10.3760/cma.j.issn.1009-2587.2020.02.011 |
[8] | Ruan Qiongfang, Xia Chen, Xie Weiguo. Histopathological and genetical diagnosis of one case of neonatal ectodermal dysplasia/skin fragility syndrome[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(6): 500-502. doi: 10.3760/cma.j.cn501120-20190329-00148 |
[9] | Lou Jihe, Zhao Xiaokai, Li Shuren, Liu Bing, Li Yancang, Zhang Jian, Wang Lei, Yang Gaoyuan, Xiao Hongtao, Xie Jiangfan, Lyu Tao, Li Xiaoliang, Xia Chengde. Early diagnosis and treatment for burn complicated with severe paroxysmal sympathetic hyperactivity[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2019, 35(8): 599-603. doi: 10.3760/cma.j.issn.1009-2587.2019.08.008 |
[10] | Zhou Jian, Wang Shuqin, Lin Yue, Zheng Dongfeng, Tan Qian. Early diagnosis of pulmonary embolism in patients with skin and soft tissue defects after trauma[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2019, 35(5): 351-355. doi: 10.3760/cma.j.issn.1009-2587.2019.05.005 |
[11] | The Burn and Trauma Branch of Chinese Geriatrics Society, Guo Guanghua, Zhu Feng, Huang Yuesheng, Wu Jun, Sun Yonghua, Xia Zhaofan, Fu Xiaobing. National experts consensus on clinical diagnosis and treatment of inhalation injury (2018 version)[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2018, 34(11): 770-775. doi: 10.3760/cma.j.issn.1009-2587.2018.11.010 |
[12] | Huang Ying, Qiu Lin, Mei Ailian, Li Jiaoxun. Meta-analysis on the diagnostic value of laser Doppler imaging for burn depth[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2017, 33(5): 301-308. doi: 10.3760/cma.j.issn.1009-2587.2017.05.009 |
[13] | Yu Yongming, Peng Xi. Attaching importance to molecular imaging techniques and promoting precision diagnosis in burns[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2017, 33(8): 469-472. doi: 10.3760/cma.j.issn.1009-2587.2017.08.002 |
[14] | Luo Gaoxing. Early precise diagnosis and reasonable management of burn wound[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2017, 33(10): 593-596. doi: 10.3760/cma.j.issn.1009-2587.2017.10.001 |
[15] | Zou Xinhua, Zhu Youpeng, Ren Guoqiang, Li Gongchi, Zhang Jing, Zou Lijun, Feng Zibo, Li Binghui. Significance of bacteria detection with filter paper method on diagnosis of diabetic foot wound infection[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2017, 33(2): 83-88. doi: 10.3760/cma.j.issn.1009-2587.2017.02.005 |
[16] | CHAI Jia-ke. Diagnosis and comprehensive management of sepsis after burn[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2013, 29(2): 105-108. doi: 10.3760/cma.j.issn.1009-2587.2013.02.003 |
[17] | PENG Yi-zhi. Clinical characteristics and diagnosis of sepsis in pediatric burn patients[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2013, 29(1): 1-3. doi: 10.3760/cma.j.issn.1009-2587.2013.01.001 |
[18] | SONG Zhen- qiang, WANG Run-xiu, NONG Qing-wen, LIN Yuan, LIU Da-en, ZHANG Li-ming, LI Feng. Clinical analysis of abdominal compartment syndrome in patients with serious burn injury[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2006, 22(6): 462-465. |
[19] | Li Tian-zeng, Xu Ying-bin, Hu Xiao-gen, Shen Rui, Peng Xiao-dong, Wu Wei-jiang, Luo Lan, Dai Xin-ming, Zou Yong-tong, Qi Shao-hai, Wu Li-ping, Xie Ju-lin, Deng Xiao-xin, Chen E, Zhang Hui-zhe. Clinical study and pathological examination on the treatment of deep partial thickness burn wound with negative charge aerosol[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2005, 21(4): 266-269. |